Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2026-01-01 @ 9:35 AM
Study NCT ID:
NCT01571557
Status:
COMPLETED
Last Update Posted:
2019-04-19
First Post:
2012-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)
Sponsor:
Allergan
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2014-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-03
First Submit QC Date:
None
Study First Post Date:
2012-04-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-06-22
Results First Submit QC Date:
None
Results First Post Date:
2015-07-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-09
Last Update Post Date:
2019-04-19
Last Update Post Date Type:
ACTUAL